St Andrews team scoops Life Sciences Award for work in antibiotic resistance

  • 21 May 2018
St Andrews team scoops Life Sciences Award for work in antibiotic resistance

Medical scientists in Scotland have been recognised for their work in antibiotic resistance.

The Orbital Diagnostics team at St Andrews won the Innovation Award at Scotland’s Life Sciences Awards for the development of a device – the Scattered Light Integrated Collector (SLIC) – which reduces the time taken to test bacteria for resistance.

Current testing frequently takes 24 hours to produce a result, although the SLIC team claims to be capable of producing a similar result in approximately 20 minutes.

This reduces risk of antibiotic resistance by helping ensure bacteria is not exposed to antibiotics unnecessarily.

As a result, the new tool should allow patients to get the right treatment, faster.

The UN has identified antibiotic resistant bacteria as a major threat to global health – with an estimated $50 trillion (£37.3tn) price tag for health care if nothing is done about it.

Team leader professor Stephen Gillespie said: “We are delighted to have won the Innovation Category at the Life Sciences awards.

“Our new technology SLIC will be an important method to help patients and to prevent the spread of antibiotic resistance.”

Subscribe to our newsletter

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Sign up

Related News

Engagement paper explores the of AI in NHS communications

Engagement paper explores the of AI in NHS communications

NHS Confederation and the AI in NHS Communications Taskforce have set out actions for using AI in communications in the health service.
Most people open to sharing health data to develop AI in the NHS

Most people open to sharing health data to develop AI in the NHS

Three quarters of people support sharing health data for the development of AI systems in the NHS, according to a Health Foundation survey.
AI tool could predict type 2 diabetes 10 years in advance

AI tool could predict type 2 diabetes 10 years in advance

Researchers at Imperial College have developed an AI tool which could identify people at risk of type 2 diabetes 10 years in advance.